Covered recipient · General Payments record
DAVID G STANDAERT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$75,510.24
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,252.50 | 8 |
| Honoraria | $450.00 | 1 |
| Food and Beverage | $198.32 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| F. Hoffmann-La Roche AG | $3,277.50 | 2 |
| Eli Lilly and Company | $2,175.00 | 2 |
| ABBVIE INC. | $2,060.93 | 5 |
| Alnylam Pharmaceuticals Inc. | $900.00 | 1 |
| Curium US LLC | $450.00 | 1 |
| Neurocrine BioSciences, Inc. | $37.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $550.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106153351 | CMS |
| ABBVIE INC. | $132.54 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153353 | CMS |
| ABBVIE INC. | $28.39 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153355 | CMS |
| ABBVIE INC. | $550.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106153357 | CMS |
| ABBVIE INC. | $800.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106153359 | CMS |
| Alnylam Pharmaceuticals Inc. | $900.00 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125833911 | CMS |
| Curium US LLC | $450.00 | 06/03/2024 | Honoraria | Undisputed | 01/23/2026 | 1080546111 | CMS |
| Eli Lilly and Company | $725.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136120380 | CMS |
| Eli Lilly and Company | $1,450.00 | 10/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136126861 | CMS |
| F. Hoffmann-La Roche AG | $345.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132999178 | CMS |
| F. Hoffmann-La Roche AG | $2,932.50 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132999182 | CMS |
| Neurocrine Biosciences, Inc. | $37.39 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150816708 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.